A team of researchers in South Korea has achieved a significant breakthrough in emergency medical technology with the development of a spray-on powder capable of sealing severe wounds in approximately one second. The innovation addresses the leading cause of death from traumatic injuries: excessive bleeding.
The research team at the Korea Advanced Institute of Science and Technology (KAIST) in Daejeon collaborated with military personnel to create a hemostatic agent specifically designed for extreme conditions. The powder, known as AGCL, rapidly transforms into a strong hydrogel barrier upon contact with wounds, offering immediate protection against blood loss.
Military Expertise Drives Practical Innovation
The development process benefited from the direct involvement of Major Kyusoon Park, who serves both as an Army officer and a doctoral candidate. His participation ensured that the technology would meet the demanding requirements of real-world combat scenarios. According to Major Park, the substance provides instant hardening capabilities under extreme conditions, including combat situations and natural disasters, while maintaining excellent storage stability and ease of use.
Major Park emphasized the limitations of existing hemostatic technologies, noting that traditional patch-type agents suffer from structural constraints and environmental sensitivity. These conventional solutions cannot adequately withstand pressure applied to wounds and demonstrate limited functionality in challenging conditions.
Advanced Chemical Process Enables Rapid Response
Professor Steve Park, who co-led the research published in the journal Advanced Functional Materials, explained the chemical mechanism behind the powder's effectiveness. The AGCL formulation reacts with cations present in blood, particularly calcium, triggering an immediate transformation into a gel state. This rapid gelation process creates an instant seal over the wound site.
The powder's three-dimensional internal structure provides exceptional absorption capacity, enabling it to absorb blood volume exceeding seven times its own weight. This characteristic significantly surpasses the performance of commercially available hemostatic agents. Additionally, the material demonstrates remarkable adhesive strength, capable of withstanding substantial manual pressure without compromising the seal.
Natural Composition Offers Multiple Benefits
The AGCL powder consists entirely of naturally derived materials, incorporating biocompatible substances such as alginate, gellan gum, and chitosan. These components work synergistically to achieve rapid hemostasis through multiple mechanisms. Alginate and gellan gum react with calcium to facilitate fast gelation and physical sealing, while chitosan bonds with blood components to enhance chemical and biological hemostatic effects.
The natural composition provides an additional advantage: the powder demonstrates antibacterial properties with an effectiveness rate of 99.9 percent, reducing the risk of infection at wound sites.
Promising Results in Experimental Testing
Animal experiments conducted by the research team yielded encouraging results regarding tissue regeneration. Professor Park reported that the tests confirmed excellent wound recovery rates, along with enhanced blood vessel and collagen regeneration. In surgical liver injury experiments, the AGCL powder significantly reduced both bleeding volume and hemostasis time compared to conventional commercial methods.
The powder also demonstrates exceptional stability, maintaining its performance characteristics for two years even when stored at room temperature in high-humidity environments. This durability makes the product suitable for immediate deployment in challenging field conditions without requiring special storage protocols.
Broad Applications Beyond Military Use
While the technology was developed primarily for national defense applications, the researchers recognize its potential for widespread civilian use. Major Park expressed his initial motivation to save soldiers' lives but acknowledged the broader implications for emergency medicine, disaster response, and healthcare delivery in developing countries and medically underserved regions.
The innovation represents a significant advancement in emergency medical care, offering first responders, military medics, and healthcare professionals a powerful tool for addressing life-threatening hemorrhages. As the technology moves toward practical implementation, it holds promise for reducing mortality rates from traumatic injuries across multiple settings, from battlefields to emergency rooms to remote disaster zones where immediate medical intervention can mean the difference between life and death.
